Lek to Enter U.S. Market with Lisinopril

Ljubljana, 24 December - The Slovene pharmaceutical company Lek has received the permit on 19 December from the U.S. Food and Drug Administration (FDA) to sell on the U.S. market the drug Lisinopril after the drug's pediatric exclusive provision expires on 29 June 2002, the company said on Monday.